Customer called to report a blood leak in the centrifuge chamber during a blood prime procedure.Customer explained the blood prime was completed at approximately 297 ml whole blood processed (wbp) at which point the patient was connected in double needle configuration.The blood leak occurred at approximately 389 ml wbp.The customer then aborted the treatment, the patient was isovolumic at this point and no blood loss occurred.The customer stated that an alarm occurred but she did not know what exact alarm had occurred.Customer stated the patient is currently being treated on a different instrument and is stable.Service order, (b)(4) was dispatched.The customer has elected not to return the kit for investigation.Therakos is attempting to obtain the smart card for investigation.
|
A review of lot c347 was performed.There were no non-conformances associated with this lot.This lot met release requirements.Trends were reviewed for complaint category, alarm #7: blood leak (centrifuge chamber).No trend was detected.No capa was initiated for this complaint category.Service order (b)(4) completed: field engineer cleaned up the blood spill and performed system checkout.No further action required.The assessment is based on information available at the time of the investigation.Therakos is trying to obtain the smart card for evaluation; however, at this time, the manufacturer has not yet received the smart card.A supplemental report will be filed when this evaluation is complete.(b)(4).
|